224 related articles for article (PubMed ID: 38275384)
21. Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
Morais E; El Mouaddin N; Schuurman S; De A
Vaccine; 2021 Sep; 39(39):5461-5473. PubMed ID: 34452775
[TBL] [Abstract][Full Text] [Related]
22. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Snietura M; Brewczynski A; Kopec A; Rutkowski T
Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
[TBL] [Abstract][Full Text] [Related]
23. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
[TBL] [Abstract][Full Text] [Related]
25. Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status.
Brewczyński A; Jabłońska B; Mrowiec S; Składowski K; Rutkowski T
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33375430
[TBL] [Abstract][Full Text] [Related]
26. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
Kondo S; Hirakawa H; Ikegami T; Uehara T; Agena S; Uezato J; Kinjyo H; Kise N; Yamashita Y; Tanaka K; Hasegawa N; Kiyuna A; Maeda H; Suzuki M; Gahana A
BMC Cancer; 2021 Jan; 21(1):87. PubMed ID: 33482765
[TBL] [Abstract][Full Text] [Related]
27. Impact of HPV status on metastatic patterns and survival in non-oropharyngeal head and neck cancer with distant metastasis.
Wang P; Zang S; Zhang M; Li G; Wang Y; Qiao Q
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3029-3039. PubMed ID: 35124745
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
29. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
[TBL] [Abstract][Full Text] [Related]
30. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK.
Lechner M; Vassie C; Kavasogullari C; Jones O; Howard J; Masterson L; Fenton T; Yarbrough W; Waller J; Gilson R
BMJ Open; 2018 Jul; 8(7):e023339. PubMed ID: 30056394
[TBL] [Abstract][Full Text] [Related]
31. The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.
Al-Sahaf S; Hunter KD; Bolt R; Ottewell PD; Murdoch C
Int J Cancer; 2019 Jan; 144(2):334-344. PubMed ID: 30191960
[TBL] [Abstract][Full Text] [Related]
32. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
33. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
[TBL] [Abstract][Full Text] [Related]
34. Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer.
Huang CC; Su YC; Chang CC; Lee WT; Ou CY; Wu YH; Wu SY; Lai YH; Huang JS; Chen KC; Hsueh WT; Tsai ST; Yen CJ; Chang JY; Tsai ML; Lin CL; Weng YL; Yang HC; Chen YS; Hsiao JR; Chang JS
Cancer Med; 2021 Jun; 10(12):4075-4086. PubMed ID: 33949155
[TBL] [Abstract][Full Text] [Related]
35. [Infection of human papillomavirus and head and neck cancer].
Song C; Zhang SK; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):39-43. PubMed ID: 36709118
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
37. De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research.
Petar S; Marko S; Ivica L
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4599-4603. PubMed ID: 33599841
[TBL] [Abstract][Full Text] [Related]
38. The Role of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
Ducatman BS
Arch Pathol Lab Med; 2018 Jun; 142(6):715-718. PubMed ID: 29848036
[TBL] [Abstract][Full Text] [Related]
39. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
[TBL] [Abstract][Full Text] [Related]
40. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal Cancer.
Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]